001     119335
005     20240228145433.0
024 7 _ |a 10.1038/ni.3638
|2 doi
024 7 _ |a pmid:27941786
|2 pmid
024 7 _ |a 1529-2908
|2 ISSN
024 7 _ |a 1529-2916
|2 ISSN
024 7 _ |a altmetric:14680157
|2 altmetric
037 _ _ |a DKFZ-2017-00090
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Herzig, Yonatan
|b 0
245 _ _ |a Transcriptional programs that control expression of the autoimmune regulator gene Aire.100
260 _ _ |a New York, NY
|c 2017
|b Nature America Inc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521726726_16575
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Aire is a transcriptional regulator that induces promiscuous expression of thousands of genes encoding tissue-restricted antigens (TRAs) in medullary thymic epithelial cells (mTECs). While the target genes of Aire are well characterized, the transcriptional programs that regulate its own expression have remained elusive. Here we comprehensively analyzed both cis-acting and trans-acting regulatory mechanisms and found that the Aire locus was insulated by the global chromatin organizer CTCF and was hypermethylated in cells and tissues that did not express Aire. In mTECs, however, Aire expression was facilitated by concurrent eviction of CTCF, specific demethylation of exon 2 and the proximal promoter, and the coordinated action of several transcription activators, including Irf4, Irf8, Tbx21, Tcf7 and Ctcfl, which acted on mTEC-specific accessible regions in the Aire locus.
536 _ _ |a 314 - Tumor immunology (POF3-314)
|0 G:(DE-HGF)POF3-314
|c POF3-314
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Nevo, Shir
|b 1
700 1 _ |a Bornstein, Chamutal
|b 2
700 1 _ |a Brezis, Miriam R
|b 3
700 1 _ |a Ben-Hur, Sharon
|b 4
700 1 _ |a Shkedy, Aya
|b 5
700 1 _ |a Eisenberg-Bord, Michal
|b 6
700 1 _ |a Levi, Ben
|b 7
700 1 _ |a Delacher, Michael
|0 P:(DE-He78)a4340add02b610f9dbdba2dc909cbd09
|b 8
700 1 _ |a Goldfarb, Yael
|b 9
700 1 _ |a David, Eyal
|b 10
700 1 _ |a Weinberger, Leehee
|b 11
700 1 _ |a Viukov, Sergey
|b 12
700 1 _ |a Ben-Dor, Shifra
|0 http://orcid.org/0000-0001-9604-1939
|b 13
700 1 _ |a Giraud, Matthieu
|b 14
700 1 _ |a Hanna, Jacob H
|0 http://orcid.org/0000-0003-2042-9974
|b 15
700 1 _ |a Breiling, Achim
|0 P:(DE-He78)75fed3121e92379462cce5d2267320b7
|b 16
|u dkfz
700 1 _ |a Lyko, Frank
|0 P:(DE-He78)a8d53a8cdc716390a6cbacdead227143
|b 17
700 1 _ |a Amit, Ido
|b 18
700 1 _ |a Feuerer, Markus
|0 P:(DE-He78)f0638edf1d3f61c0d7ebb587f511733f
|b 19
700 1 _ |a Abramson, Jakub
|b 20
773 _ _ |a 10.1038/ni.3638
|g Vol. 18, no. 2, p. 161 - 172
|0 PERI:(DE-600)2026412-4
|n 2
|p 161 - 172
|t Nature immunology
|v 18
|y 2017
|x 1529-2916
909 C O |p VDB
|o oai:inrepo02.dkfz.de:119335
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)a4340add02b610f9dbdba2dc909cbd09
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)75fed3121e92379462cce5d2267320b7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)a8d53a8cdc716390a6cbacdead227143
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)f0638edf1d3f61c0d7ebb587f511733f
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-314
|2 G:(DE-HGF)POF3-300
|v Tumor immunology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT IMMUNOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT IMMUNOL : 2015
920 1 _ |0 I:(DE-He78)A130-20160331
|k A130
|l Epigenetik
|x 0
920 1 _ |0 I:(DE-He78)D100-20160331
|k D100
|l Immuntoleranz
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A130-20160331
980 _ _ |a I:(DE-He78)D100-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21